Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany

Apceth announces that it has started the commercial manufacture of Zyntelgo, after health insurance companies in Germany agree to pricing structure.

WuXi Biologics acquires first EU drug product facility through Bayer deal

WuXi Biologics will add Bayer’s Leverkusen drug product facility, as part of its continued expansion into the European market.

FDA places Innate cancer trial on partial clinical hold over CMO issue

The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.

Astellas continues to make deals, partnering with Adaptimmune

The newly established deal includes the co-development of up to three T-cell therapies, by utilizing the latter’s stem-cell derived allogeneic T-cell platform.

Lilly acquires Dermira for $1.1bn, expands dermatology portfolio

Eli Lilly set to acquire dermatological drugs developer, Dermira, in an $1.1bn all-cash deal, adding commercial and late-stage drugs to its portfolio.